Biogen Inc. Business Finance Contracts & Agreements
45 Contracts & Agreements
- Credit Agreements (6 contracts)
- Escrow Agreements (1)
- Indenture Agreements (6)
- Investor Rights Agreements (1)
- Note Agreements (3)
- Purchase Agreements (1)
- Release Agreements (1)
- Stock Agreements (24)
- Underwriting Agreements (2)
- Credit Agreement, dated as of August 12, 2024, among Biogen Inc., Bank of America, N.A., as administrative agent, swing line lender and the L/C issuer, and the other lenders party... (Filed With SEC on August 14, 2024)
- Form of restricted stock unit award agreement for non-employee Director's under the Biogen Inc. 2024 Omnibus Equity Plan (Filed With SEC on August 1, 2024)
- Form of restricted stock unit award agreement under the Biogen Inc. 2024 Omnibus Equity Plan (Filed With SEC on August 1, 2024)
- Credit Agreement, dated as of August 28, 2023 among Biogen Inc., JPMorgan Chase Bank N.A., as administrative agent and the other lenders party thereto (Filed With SEC on September 1, 2023)
- Registration Rights Agreement, dated February 16, 2021, between Biogen Inc. and Deutsche Bank Securities Inc. and Citigroup Global Markets, Inc. with respect to the 3.250% Senior... (Filed With SEC on February 16, 2021)
- Form of 3.250% Senior Notes due 2051, in the form of a Global Note bearing a Regulation S legend (Filed With SEC on February 16, 2021)
- Form of 3.250% Senior Notes due 2051, in the form of a Global Note bearing a private placement legend (Filed With SEC on February 16, 2021)
- Third Supplemental Indenture, dated February 16, 2021, between Biogen Inc. and U.S. Bank National Association (Filed With SEC on February 16, 2021)
- Second Supplemental Indenture, dated April 30, 2020, between Biogen Inc. and U.S. Bank National Association, including the forms of Global Notes attached as Exhibit A and Exhibit... (Filed With SEC on February 3, 2021)
- Second Supplemental Indenture, dated April 30, 2020, between the Company and U.S. Bank National Association, including the forms of Global Notes attached as Exhibit A and Exhibit... (Filed With SEC on April 30, 2020)
- Underwriting Agreement, dated April 27, 2020, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the... (Filed With SEC on April 30, 2020)
- Credit Agreement, dated as of January 28, 2020, among Biogen Inc., Bank of America, N.A., as administrative agent, swing line lender and the L/C issuer, and the other lenders... (Filed With SEC on February 3, 2020)
- Form of market stock unit award agreement under the Biogen Inc. 2017 Omnibus Equity Plan (for grants commencing in July 2019) (Filed With SEC on July 24, 2019)
- Form of restricted stock unit award agreement (2018 one-time transition grant) under the Biogen Inc. 2017 Omnibus Equity Plan (Filed With SEC on April 24, 2018)
- MARKET STOCK UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN INC. 2017 OMNIBUS EQUITY PLAN (Filed With SEC on July 25, 2017)
- RESTRICTED STOCK UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN INC. 2017 OMNIBUS EQUITY PLAN (Filed With SEC on July 25, 2017)
- BIOGEN INC., as Issuer and U.S. BankNational Association, as Trustee First Supplemental Indenture Dated as of September 15, 2015 TABLE OF CONTENTS (Filed With SEC on September 16, 2015)
- BIOGEN INC. and U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Debt Securities Dated as of September 15, 2015 CROSS-REFERENCE TABLE (Filed With SEC on September 16, 2015)
- Biogen Inc. 2.900%Senior Notes due 2020 3.625% Senior Notes due 2022 4.050% Senior Notes due 2025 5.200% Senior Notes due 2045 Underwriting Agreement (Filed With SEC on September 14, 2015)
- CREDIT AGREEMENT Dated as of August 28, 2015 among BIOGEN INC. as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, GOLDMAN SACHS... (Filed With SEC on September 1, 2015)
- MARKET STOCK UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN IDEC INC. 2008 OMNIBUS EQUITY PLAN (Filed With SEC on April 23, 2014)
- Exhibit A REAFFIRMATION OF RELEASE OF CLAIMS (Filed With SEC on February 6, 2014)
- CREDIT AGREEMENT Dated as of March 14, 2013 among BIOGEN IDEC INC. as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, CREDIT SUISSE... (Filed With SEC on April 25, 2013)
- ASSET PURCHASE AGREEMENT by and among ELAN PHARMA INTERNATIONAL LIMITED, ELAN PHARMACEUTICALS, INC. and BIOGEN IDEC INTERNATIONAL HOLDING LTD. Dated as of February 5, 2013 (Filed With SEC on February 12, 2013)
- EX-10.2 Form of market stock unit award agreement under the 2008 Omnibus Equity Plan (Filed With SEC on April 20, 2010)
- Ex-10.1 Amendment No.1 to Credit Agreement (Filed With SEC on April 17, 2009)
- Ex-10.45 Amendment to Biogen, Inc. 1985 Non-Qualified Stock Option Plan dated October 13, 2008 (Filed With SEC on February 6, 2009)
- Ex-4.4 Amendment No. 2 to Amended and Restated Rights Agreement between Biogen Idec and Mellon Investor Services LLC dated as of January 22, 2009 (Filed With SEC on February 6, 2009)
- Ex-10.2 Form of nonqualified stock option award agreement (Filed With SEC on August 1, 2008)
- Ex-10.1 Form of resticted stock unit award agreement (Filed With SEC on August 1, 2008)
- EX-10.5 Amendment to IDEC Pharmaceuticals Corporation 1993 Non-Employee Directors Stock Option Plan dated April 18, 2008 (Filed With SEC on July 22, 2008)
- EX-10.4 Amendment to IDEC Pharmaceuticals Corporation 1988 Stock Option Plan dated April 18, 2008 (Filed With SEC on July 22, 2008)
- EX-10.3 Amendment to Biogen, Inc. 1987 Scientific Board Stock Option Plan dated April 18, 2008 (Filed With SEC on July 22, 2008)
- EX-10.2 Amendment to Biogen, Inc. 1985 Non-Qualified Stock Option Plan dated April 18, 2008 (Filed With SEC on July 22, 2008)
- TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS 1 SECTION 1.1. Certain Terms Defined in the Indenture 1 SECTION 1.2. Definitions 2 ARTICLE II. FORM AND TERMS OF THE NOTES 5 SECTION... (Filed With SEC on March 4, 2008)
- Ex-10.22 1985 Non-Qualified Stock Option Plan (Filed With SEC on February 14, 2008)
- Ex-10.1 Form of Grant Notice (Restricted Stock Units) (Filed With SEC on September 15, 2005)
- Ex-10.1 Purchase and Sale Agreement and Joint Escrow Instructions (Filed With SEC on July 27, 2005)
- EX-10.1 AMENDMENT TO 1998 STOCK PLAN (Filed With SEC on August 9, 2004)
- EX-4.2 SPECIMEN COMMON STOCK CERTIFICATE (Filed With SEC on March 10, 2004)
